Tehran University of Medical Sciences

Science Communicator Platform

Faculty Members have conducted research related to the A Randomized, Two-Armed, Double-Blind, Single-Dose, Cross-Over, Bioequivalence Clinical Trial to Compare Pharmacokinetic Parameters and Safety of Recombinant Human Factor Viii With Fc Fusion Produced by Aryogen Pharmed Company Versus Elocta® (Reference Product) in Previously Treated Patients With Severe Haemophilia A
Shaban Alizadeh
Shaban Alizadeh

Professor of Laboratory Sciences

Department Hematology

School of Allied Medical Sciences

Zoonoses Research Center

Tehran University of Medical Sciences

All Documents
14. Sglt2 Inhibitors and Ampk: The Road to Cellular Housekeeping?, Cell Biochemistry and Function (2024)
63. The Role of Micrornas in Myeloproliferative Neoplasia, International Journal of Hematology-Oncology and Stem Cell Research (2016)
71. Factor Xiii Deficiency in Iran: A Comprehensive Review of the Literature, Seminars in Thrombosis and Hemostasis (2015)
75. Short View of Leukemia Diagnosis and Treatment in Iran, International Journal of Hematology-Oncology and Stem Cell Research (2015)